$69.5 Million is the total value of ISZO CAPITAL MANAGEMENT LP's 3 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CDMO | Sell | AVID BIOSERVICES INC | $32,369,000 | +34.7% | 4,220,148 | -6.9% | 46.59% | +46.5% |
| NTP | Sell | NAM TAI PPTY INC | $22,112,000 | -35.7% | 2,568,170 | -32.7% | 31.83% | -30.0% |
| XPEL | Sell | XPEL INC | $14,997,000 | -10.7% | 1,023,699 | -28.1% | 21.58% | -2.9% |
| TOCA | Exit | TOCAGEN INC | $0 | – | -565,925 | -100.0% | -0.50% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NAM TAI PPTY INC | 16 | Q3 2022 | 60.5% |
| AVID BIOSERVICES INC | 13 | Q4 2021 | 46.6% |
| XPEL INC | 10 | Q4 2021 | 22.3% |
| TARO PHARMACEUTICALS INDUS LTD | 8 | Q4 2015 | 85.7% |
| AMERCO | 8 | Q4 2015 | 11.2% |
| NATHANS FAMOUS INC NEW | 7 | Q1 2017 | 68.9% |
| MMA CAP MGMT LLC | 7 | Q1 2017 | 17.8% |
| CBL & ASSOC PPTYS INC | 6 | Q3 2023 | 95.2% |
| LIFECORE BIOMEDICAL INC | 6 | Q4 2022 | 35.1% |
| CRYO-CELL INTL INC | 6 | Q4 2022 | 11.0% |
View ISZO CAPITAL MANAGEMENT LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View ISZO CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.